Renal Cell Carcinoma Prediction Tool This nomogram predicts the chance that newly diagnosed renal cell carcinoma will not recur five years after surgery open calculator

Researchers at Memorial Sloan-Kettering have developed a nomogram that combines prognostic factors to predict the likelihood of recurrence after surgery for renal cell carcinoma. This nomogram can be used to predict the five-year probability of treatment failure among patients with newly-diagnosed renal cell carcinoma.

Our recommendation is that these tools be used by physicians. Patients should use these tools only in consultation with their physicians.